The importance of the margin of resection and radiotherapy in retroperitoneal liposarcoma
- 23 November 2020
- journal article
- research article
- Published by Elsevier in The American Journal of Surgery
- Vol. 221 (3) , 554-560
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trialThe Lancet Oncology, 2020
- Role of radiation therapy for retroperitoneal sarcomas: An eight‐institution study from the US Sarcoma CollaborativeJournal of Surgical Oncology, 2019
- Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working GroupCancer, 2019
- Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and SizeSarcoma, 2018
- Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2018
- Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology databaseThe Lancet Oncology, 2016
- Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcomaJournal of Surgical Oncology, 2015
- Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patientsActa Oncologica, 2014
- Diagnosis and management of lipomatous tumorsJournal of Surgical Oncology, 2008
- IMRT of large fields: whole-abdomen irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002